Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

Na minha lista:
Bibliografiske detaljer
Udgivet i:Aliment Pharmacol Ther
Main Authors: Prentice, Ralley E., Tjandra, Doug, Garg, Mayur, Lubel, John S., Fourlanos, Spiros, Johnson, Doug, Al‐Ani, Aysha, Christensen, Britt
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Letters to the Editors
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537250/
https://ncbi.nlm.nih.gov/pubmed/33105980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16063
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker